Lidocaine Ointment
Product Images NDC 51672-3020

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lidocaine (NDC 51672-3020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lidocaine 01)

FDA Label Image

Principal Display Panel (30 g Tube Carton)

Principal Display Panel (30 g Tube Carton)
This is a medication product for external use only, containing a mixture of lycol 400, polyethylene glycol 3350, and propylene giycol. It is not for use in the eyes and should be kept out of the reach of children. The tube has a child-resistant cap, and usage instructions can be found in the package insert. The medication should be stored at 20° to 25°C (68° to 77°F) and should be protected from freezing. The product is a 5% Lidocaine USP ointment, with a net weight of 35.44 g (1% 02). The tube has a registered trademark of TARD, and it is distributed by Taro Pharmaceuticals U.S.A.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.